A randomized multicenter phase II trial on the efficacy of a hydrocolloid dressing containing ceramide with a low-friction external surface for hand-foot skin reaction caused by sorafenib in patients with renal cell carcinoma

Autor: Shinohara, N. *, Nonomura, N., Eto, M., Kimura, G., Minami, H., Tokunaga, S., Naito, S.
Zdroj: In Annals of Oncology February 2014 25(2):472-476
Databáze: ScienceDirect